Biosimilar Monoclonal Antibodies Mabs Market By Product Type (Rituximab Biosimilars, Infliximab Biosimilars, Trastuzumab Biosimilars, Adalimumab Biosimilars, Bevacizumab Biosimilars), Application (Oncology, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals, Clinics, Research Institutes) & Region for 2024-2031
Published on: 2024-07-15 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel